4
Changes in Ownership
Jazz Pharmaceuticals plc Filed Acc 0001765581-22-000002
Chairman & CEO sold 5,791 shares at an average $127.85 ($740,387)
- Chairman & CEO acquired 9,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
COZADD BRUCE C · Chairman & CEO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-03 | Exercise or conversion : show line 1 in the form | +9,700 | $46.83 | $454,251 | 328,251 | D |
| 2022-01-03 | Sale : show line 2 in the form | −1,819 | $126.72 | $230,504 | 326,432 | D |
| 2022-01-03 | Sale : show line 3 in the form | −1,181 | $127.58 | $150,672 | 325,251 | D |
| 2022-01-03 | Sale : show line 4 in the form | −2,651 | $128.67 | $341,104 | 322,600 | D |
| 2022-01-03 | Sale : show line 5 in the form | −140 | $129.34 | $18,108 | 322,460 | D |
| Open-market sales · 5,791 sh · avg $127.85 · $740,387 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −9,700 | 67,832 | D |
Loading xslF345X03/edgardoc.xml…